Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Atezolizumab Post Chemo-Radiation.
Lili Jose SaadeArafat Hussein TfayliPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
The administration of Atezolizumab carries a significant risk of developing pneumonitis following chemoradiation therapy for NSCLC. The presence of certain factors and tumor characteristics might affect the chances of having pneumonitis. However due to our small sample size, definitive conclusions could not be drawn.
Keyphrases
- locally advanced
- interstitial lung disease
- small cell lung cancer
- rectal cancer
- systemic sclerosis
- photodynamic therapy
- advanced non small cell lung cancer
- rheumatoid arthritis
- radiation therapy
- squamous cell carcinoma
- drug delivery
- cancer therapy
- combination therapy
- idiopathic pulmonary fibrosis
- radiation induced
- brain metastases